Abstract
This study aimed at examining any relation between the circadian variation in blood pressure (BP) in human pregnancy and fetal growth. A prospective study included 52 pregnant women monitored during the third trimester of pregnancy. There were 33 uncomplicated pregnancies with normal fetal growth (Group 1) and 19 pregnancies complicated by intrauterine growth retardation (IUGR), confirmed at birth (Group 2). Ten women (five in each group) had pregnancy-induced hypertension. All women were hospitalized and followed a similar daily routine. BP was recorded with an automatic wearable device. Measurements were obtained every 20 min for 24 ± 1 h. BP profiles were analyzed by conventional statistical methods and by cosinor, involving the least squares fit of cosine curves with an anticipated period (24 h) to the data. BP parameters, fetal outcome, demographic and obstetric characteristics were compared between the two groups. Logistic regression and multivariate analyses were used to assess factors putatively associated with fetal outcome. The circadian amplitude of diastolic BP was found to be larger in normotensive women with IUGR. As gauged by odds ratios (OR), the circadian amplitude of diastolic BP (OR = 1.7, 95% CI: 1.1–2.8; P = 0.03) and hematocrit (OR = 1.4, 95% CI: 1.0–1.9; P = 0.04) were the only variables positively and independently associated with IUGR. In the presence of maternal hypertension, the circadian amplitude of systolic BP was negatively associated with IUGR (OR = 0.7, 95% CI: 0.5–1.0; P = 0.03). A larger circadian variation in diastolic BP, rather than a difference in the mean value of systolic or diastolic BP, was found to be statistically significantly associated with IUGR. This study adds another condition in which the circadian BP amplitude constitutes a harbinger of elevated risk, apart from an association with a shortened lifespan in the absence or presence of malignant hypertension and with an increased risk of stroke and nephropathy reported earlier.
Keywords: Blood pressure, Circadian rhythm, Human pregnancy, Intrauterine growth retardation (IUGR), Pregnancy-induced hypertension
1. Introduction
In utero growth retardation (IUGR) is reportedly associated with raised blood pressure (BP) values in adulthood and with decreased arterial compliance in the trunk and legs [1,2]. During pregnancy, high maternal BP values are reported to adversely affect fetal growth and to be associated with an increased risk of intrauterine growth restriction, more so in the presence of pre-eclampsia than in the presence of gestational hypertension [3]. BP-lowering therapy could also negatively affect fetal growth, a larger treatment-associated decrease in BP corresponding to a higher odds ratio of impaired fetal growth [4].
The mechanism by which an elevated BP affects fetal growth has been related to changes in vascular resistance, but the BP coordination in idiopathic IUGR is not known. Since a compromised placental vasculature or blood volume reduction may be involved [5,6], any local vasoconstriction can be expected to affect the BP profile. Because BP is highly variable from moment to moment, a single BP measurement is neither accurate nor adequate in diagnosing normotension (or hypertension). With respect to monitoring for a single circadian cycle, as done herein, the same qualification applies to this study’s results insofar as references for a given individual woman are concerned. With this limiting qualification, BP variability in itself may be a source of useful information. Circadian hyper-amplitude-tension (CHAT), defined as an excessive circadian BP variation (BP overswinging), has been associated with a large increase in cardiovascular morbidity, cerebral ischemic events and nephropathy in particular [7–9] and with higher values of the left ventricular mass index, reflecting an increased risk of target organ damage [10].
BP exhibits a circadian periodic variation with lower values during the night and higher values during the day [11–14]. This rhythmicity is also present throughout pregnancy [15–17]. An altered circadian pattern has been reported in pregnancy-induced hypertension [18] and in severe preeclamsia, where a complete reversal of the BP variation has been reported [19,20]. Single BP measurements are then only a poor indicator of the complex adaptation of the maternal circulation, while BP variability needs to be considered [7–11,13,21–24].
This study aimed at examining BP variability during pregnancy and at assessing any influence of maternal BP on fetal growth, accounting for parity, smoking, volume constriction, and diet.
2. Subjects and methods
Fifty-two women with a singleton pregnancy, who attended the prenatal clinic of the hospital volunteered to enter the study and all provided informed consent. Ten women were diagnosed as having pregnancy-induced hypertension (PIH), defined by an anamnestic evaluation negative for pre-pregnancy hypertension and a BP value at rest above 140/90 mmHg on two different occasions. The remainder had acceptable BP values at the time of testing and remained normotensive until delivery. Gestational age was determined by early ultrasound examination at less than 12 weeks. IUGR was diagnosed as a growth rate pattern monitored by ultrasonography in the lower 10th percentile, adjusted for gender, gestational age, and national standards [25], confirmed by a birth weight in the lower 10th percentile [26]. None of the fetuses had any malformations or diseases other than IUGR. None of the pregnant women was affected by medical diseases other than PIH. They did not receive any medications, except for iron and vitamins.
All patients were hospitalized for at least 2 days during which they were encouraged to follow the same daily routine. Lights were turned off from 22:00 to 06:00 h, and meals were served at 08:00, 12:00 and 19:00 h. On the second day, blood was taken for determination of hemoglobin (Hb) and hematocrit (Ht), and maternal BP and heart rate (HR) were recorded oscillometrically at 20-min intervals for 24 ± 1 h, using a portable automatic device (Space labs Holter PA 5200) [27].
BP and HR measurements were plotted as function of time and analyzed by single cosinor [28,29]. This approach consists of fitting by least squares a cosine function with a given period (24 h) to the data. Point and interval (95% confidence interval) estimates are thus obtained for the MESOR, a rhythm-adjusted mean, for the double circadian amplitude, an estimate of the predictable extent of change within a day, and for the acrophase, a measure of the timing of overall high values recurring each day. Rhythm detection is established by means of the zero-amplitude test. Statistical significance is reached for a probability less than 5%. Results were summarized for each group by population-mean cosinor [28,29] and compared by parameter tests [30].
The Student t-test and/or the Mann–Whitney test were also used to compare continuous variables, depending on whether the normality of their distribution could be validated or not. Odds ratios (OR) were computed to assess the relationship between IUGR and categorical variables such as gender, smoking, PIH, gravidity, and parity. Both linear and logistic regression models [31] tested the association of fetal growth pattern with continuous and dichotomic variables, treating outcomes respectively as a continuous or as a dichotomic variable. Continuous independent variables were entered as such in the model or after categorization [32]. Analyses were carried out overall and after removing women with PIH. Multivariate analyses of variance were also performed, taking into consideration Ht, the presence of hypertension, and chronobiological end-points (MESOR, circadian amplitude and acrophase of BP), in order to obtain an “adjusted” estimation of their association with IUGR.
3. Results
All women were first compared between IUGR with AGA (appropriate size for gestational age) pregnancies, irrespective of the maternal obstetric history. Fetal growth pattern was within the reference range for gestation in 33 women (Group 1: AGA, 28 with normotension and five with PIH). It was below the 10th percentile in 19 women (Group 2: IUGR, 14 with normotension and five with PIH). Parity, gestational age at testing, pre-pregnancy weight, weight gain, body mass index, and the number of smokers were similar between the two groups, but Hb and Ht were statistically significantly higher in IUGR than in AGA pregnancies (P < 0.01), Table 1a. Cesarean sections were also more common among IUGR than among AGA pregnancies, Table 1b.
Table 1.
| Table 1a. Comparison of demographic and clinical variables between AGA and IUGR pregnancies
| ||||||
|---|---|---|---|---|---|---|
| AGA (n = 33) | IUGR (n = 19) | Mann-Whitney | ||||
| mean | S.D. | mean | S.D. | |||
| AGE (years) | 31.15 | 5.37 | 30.58 | 4.05 | NS | |
| GESTATIONAL AGE (weeks) | 33.48 | 5.93 | 33.73 | 2.64 | NS | |
| Pre-pregnancy | 58.12 | 9.59 | 55.89 | 5.66 | NS | |
| MATERNAL WEIGHT (kg) | ||||||
| WEIGHT INCREASE (kg) | 10.18 | 3.3 | 9.95 | 2.12 | NS | |
| MATERNALBMI (kg/m2) | 22.11 | 4.12 | 21.05 | 2.01 | NS | |
| Hb (g/dl) | 11.25 | 1.15 | 12.07 | 1,13 | 0.01 | |
| Ht(%) | 33.68 | 2.77 | 35.95 | 3.11 | 0.01 | |
| FETAL WEIGHT (g) | 3072 | 954 | 1930 | 486 | 0.01 | |
| Table 1b. Comparison of demographic and clinical variables between AGA and IUGR pregnancies
| ||||||
| AGA (n = 33) | IUGR (n = 19) | χ2 (P); OR [95% CI] | ||||
|
| ||||||
| n | % | n | % | |||
| smokers | Yes | 10 | 30.3 | 5 | 26.3 | 0.093 (0.760); 0.82 [0.23, 2.90] |
| No | 23 | 69.7 | 14 | 73.7 | ||
| First pregnancy | Yes | 11 | 33.3 | 10 | 52.6 | 1.865 (0.172); 2.22 [0.70, 7.06] |
| No | 22 | 66.7 | 9 | 47.4 | ||
| Pluriparae | Yes | 12 | 36.4 | 5 | 26.3 | 0.553 (0.457); 0.63 [0.18, 2.17] |
| No | 21 | 63.6 | 14 | 73.7 | ||
| PIH | Yes | 5 | 15.1 | 5 | 26.3 | 0.968 (0.325); 2.00 [0.50, 8.08] |
| No | 28 | 84.9 | 14 | 73.7 | ||
| Cesarean section | Yes | 14 | 42.4 | 16 | 84.2 | 8.626 (0.003); 7.24 [1.76, 29.7] |
| No | 19 | 57.6 | 3 | 18.8 | ||
AGA: Appropriate size for gestational age; IUGR: intrauterine growth retardation;
Hb: Hemoglobin; Ht: Hematocrit; OR: Odds Ratio;
CI: Confidence Interval; NS: Not statistically significant (P > 0.05).
A statistically significant circadian BP rhythm could be demonstrated on an individualized basis for all normotensive women and for all but four women with PIH. Overall, the circadian amplitude of diastolic BP was found to be larger among IUGR, than among AGA pregnancies (P < 0.01 from Mann–Whitney test), whereas the circadian amplitude of systolic BP was slightly smaller among IUGR than among AGA pregnancies. Of all variables examined herein, multivariate logistic regression analyses only found Ht and the circadian amplitude of BP to be statistically significantly associated with IUGR, Table 2 (left).
Table 2.
Results of multivariate logistic regression analyses
| All women (n = 52) | After removal of women with PIH (n = 42) | |||
|---|---|---|---|---|
| Adjusted OR (95%CI) | P | Adjusted OR (95%CI) | p | |
| PIH | 2.5 (0.2–26.8) | 0.44 | - | - |
| Hematocrit | 1.3 (1.0–1.7) | 0.03 | 1.4 (1.0–1.9) | 0.04 |
| SBP MESOR | 1.0 (0.9–1.1) | 0.76 | 1.0 (0.9–1.2) | 0.83 |
| DBP MESOR | 1.1 (0.9–1.2) | 0.28 | 1.0 (0.8–1.2) | 0.99 |
| SBP Amplitude | 0.7 (0.5–1.0) | 0.03 | 0.8 (0.6–1.1) | 0.17 |
| DBP Amplitude | 1.8 (1.1–2.7) | 0.01 | 1.7 (1.1–2.8) | 0.03 |
OR: Odds ratio; PIH: Pregnancy-Induced Hypertension; CI: confidence interval;
SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure;
MESOR: Midline Estimating Statistic Of Rhythm, rhythm-adjusted mean value;
Amplitude: Half the extent of predictable variation within a day.
After excluding women with PIH, the circadian amplitude of diastolic BP remained statistically significantly larger among IUGR, than among AGA pregnancies (mean ± S.D.: 9.3 ± 1.7 vs. 7.4 ± 3.2 mmHg, P = 0.01), Table 3. Multivariate logistic regression analyses on these 42 normotensive women find the circadian amplitude of diastolic BP and Ht to remain independently associated with IUGR, Table 2 (right). The relation with the circadian amplitude of systolic BP, however, is no longer statistically significant, Table 2 (right).
Table 3.
Comparison of circadian BP rhythm characteristics between AGA and IUGR normotensive pregnancies (after removing women with PIH)
| AGA (n = 28) | IUGR (n = 14) | ||||
|---|---|---|---|---|---|
| mean | S.D. | Mean | S.D. | ||
| SBP MESOR (mmHg) | 115.08 | 22.41 | 114.83 | 9.13 | NS |
| DBP MESOR (mmHg) | 76.11 | 11.31 | 72.69 | 8.87 | NS |
| SBP Amplitude (mmHg) | 8.57 | 4.33 | 8.44 | 2.37 | NS |
| DBP Amplitude (mmHg) | 7.43 | 3.19 | 9.29 | 1.73 | 0.01 |
| SBP acrophase(degrees) | −218(14:40) | 50 | −222 (13:40) | 64 | NS |
| DBP acrophase (degrees) | −220 (14:40) | 44 | −205 (13:40) | 59 | NS |
AGA: Appropriate for gestational age; IUGR: Intrauterine Growth Retardation
S.D.: standard deviation;
SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure;
MESOR: Midline Estimating Statistic Of Rhythm, rhythm-adjusted mean value;
Amplitude: Half the extent of predictable variation within a day;
Acrophase: Timing of overall high values recurring each day, expressed in (negative) degrees, with 360° equated to 24 h, and 0° set to local midnight.
4. Discussion and conclusion
This study shows that the circadian amplitude of diastolic BP is related to fetal growth independently of Ht (and Hb). This association holds true and when women with PIH are excluded. No association was found, however, with the MESOR of BP. The circadian BP amplitude is a measure of the extent of oscillation in BP values around the MESOR. Despite an acceptable BP MESOR, pregnancies complicated by IUGR are characterized by increased deviations of the maternal BP from the MESOR as compared to uncomplicated pregnancies.
The mechanisms for an increase in BP during daytime are not known. It is possible that during the night the fluid re-absorption can compensate the low blood volume or that the pressure effect of vasoactive peptide is increased in a volume - depleted vasoconstrictive state. The latter is more likely to be present — or increased — during the day, when sympathetic activity is increased [33] and venous BP tone is low in relation to the standing position [34], than during the night. We recently found that ANF is increased in cases of IUGR with acceptable mean BP values [35]. Its vasodilatory action may have acompensatory effect, especially in the placental perfusion, where receptors for ANP have been found, thus preventing a further increase in vasoconstriction but also reducing the BP mean.
The loss of circadian BP rhythmicity and a paradoxical increase in BP during sleep has been reported in PIH patients until a complete reversal of the circadian pattern [15,19,36–39]. In this study, most of the women had an acceptable BP profile. The circadian amplitude of systolic BP amplitude was found to be positively associated with the presence of PIH but negatively associated with the diagnosis of IUGR. An increase in the circadian BP amplitude had been observed to occur before an increase in the MESOR of BP in the stroke-prone spontaneously-hypertensive Okamoto rat (handled for measurements) [40], perhaps reflecting an increased vascular reactivity. An increase in vascular responsiveness has been described in hypertensive pregnant patients [19], and it is possible that the circadian amplitude of systolic BP could become a useful marker in pregnancy, but the small sample size of this study does not allow us to draw definitive conclusions.
The circadian amplitude of SBP was negatively rather than positively related to IUGR in the presence of PIH. As suggested by Easterling [41,42], PIH patients move from a hyper-dynamic low-resistance state to a state of high resistance when fetal growth is compromised. The first stage may be reflected by an increase in the circadian amplitude of systolic BP, whereas the second stage may be associated with a decrease in the circadian amplitude of systolic BP. An increase in BP may allow placental perfusion to be maintained. Reportedly, in PIH patients the mean BP, cardiac output and ejection volume are lower in pregnancies complicated by IUGR [43,44]. In IUGR, the increase in maternal BP may stem from a compensatory mechanism that is jeopardized by anti-hypertensive treatment [45].
An increase in fetal and neonatal death rate associated with low diastolic BP during pregnancy has been reported [46]. The relation between mean diastolic BP values during the last 3 months of pregnancy and neonatal weight suggests that fetal growth is affected when the diastolic BP is above 90 or below 65 mmHg [46,47]. A lower birth weight associated with an extremely low BP has also been reported [48]. Most of these studies were not done chonobiologically, however, being based on BP spotchecks rather than on serial measurements taken during the night as well as during the day.
The absence of a decrease in hematocrit and in MAP is reportedly correlated with impaired fetal growth [49]. Doppler flow measurements show that the hypervolemic hemodilution is of advantage for the mother and the fetus, while a reduction in blood volume expansion during pregnancy is associated with a heightened risk of IUGR [50]. IUGR has already been reported to be associated with increased Hb and Ht values [51,52], in keeping with results herein.
It is well known that both pre-pregnancy weight and weight gain can strongly influence BP [53] and fetal growth [54,55]. In this study, however, there was no difference in either variable between women with uncomplicated pregnancies and women with pregnancies complicated by IUGR, or between normotensive women and women with PIH. It is possible that the quality of the food more than the total amount of weight increase can affect fetal growth, but the negative results have to be qualified by the small sample size of this study.
A relation between BP variability and target organ damage is another possible explanation. It is not known which component of the arterial pressure leads to vascular damage. It might be expected that individuals with increased BP variability may suffer more vascular damage. But animal studies indicate that increased BP variability, by sectioning the carotid sinus and aortic beroreceptor nerves, does not necessarily lead to accelerated vascular damage, although this question has received little attention. In clinical studies, the relationship of BP variability to cardiovascular disease risk was shown to be nonlinear: the circadian amplitude of BP has to exceed a threshold value for risk to be increased [56, see also 57]. Larger circadian amplitude of BP in children with a positive vs. negative family history of high BP and/or related cardiovascular disease was also observed [58]. And a larger circadian BP amplitude was found in patients with an intermediate value of the left ventricular mass index (LVMI) but no increase in BP MESOR, observed only at higher LVMI values [59]. Theoretically, the larger circadian amplitude of diastolic BP found herein in the presence of IUGR could reflect the pre-hypertension state observed in non-pregnant adults [60]. If so, it is conceivable that normotensive pregnancies complicated by IUGR may eventually evolve toward MESOR-hypertension if pregnancy would last long enough. The known influence of PIH on fetal growth would then be matched in reverse by an effect of IUGR on maternal BP.
In conclusion, of clinical interest is the finding herein that a larger circadian amplitude of diastolic BP is statistically significantly and independently associated with the presence of IUGR, irrespective of the maternal BP MESOR, whereas in presence of high BP, the circadian amplitude of systolic BP is inversely related to IUGR, suggesting opposite effects of IUGR and PIH on maternal BP variability. Hematocrit (and hemoglobin) was also found to be associated with fetal growth retardation, independently of BP. The reader is referred to the literature for associations of the circadian BP amplitude with lifespan [61–63] and for a comparison of the relative merits of assessing the circadian variation versus a classification into ‘dippers’ and non-dippers’ according to the day-night ratio [64,65].
Acknowledgments
GM-13981 (FH), Dr. h.c. mult. Earl Bakken Fund (GC, FH) and University of Minnesota Supercomputing Institute (GC, FH).
References
- 1.Martyn CN, Barker DJ, Jespersen S, Greenwald S, Osmond C, Berry C. Growth in utero, adult blood pressure, and arterial compliance. British Heart Journal. 1995;73:116–21. doi: 10.1136/hrt.73.2.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Cheung YF, Wong KY, Lam BC, Tsoi NS. Relation of arterial stiffness with gestational age and birth weight. Archives of Disease in Childhood. 2004;89:217–21. doi: 10.1136/adc.2003.025999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Xiong X, Mayes D, Demianczuk N, Olson DM, Davidge ST, Newburn-Cook C, et al. Impact of pregnancy-induced hypertension on fetal growth. American Journal of Obstetrics and Gynecology. 1999;180:207–13. doi: 10.1016/s0002-9378(99)70176-6. [DOI] [PubMed] [Google Scholar]
- 4.von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet. 2000;355:87–92. doi: 10.1016/s0140-6736(98)08049-0. [DOI] [PubMed] [Google Scholar]
- 5.Hayashi TT. Nucleic acid metabolism of placenta and fetus. Obstetrics and Gynecology Annual. 1977;6:11–22. [PubMed] [Google Scholar]
- 6.Thoruburg KL. Fetal response to intrauterine stress. Ciba Foundation Symposium. 1991;156:17–29. doi: 10.1002/9780470514047.ch3. [DOI] [PubMed] [Google Scholar]
- 7.Otsuka K, Cornélissen G, Halberg F, Oehlert G. Excessive circadian amplitude of blood pressure increases risk of ischemic stroke and nephropathy. Journal of Medical Engineering and Technology. 1997;21:23–30. doi: 10.3109/03091909709030299. [DOI] [PubMed] [Google Scholar]
- 8.Cornélissen G, Schwartzkopff O, Halberg F, Otsuka K, Watanabe Y. 7-day ambulatory monitoring for adults with hypertension and diabetes. American Journal of Kidney Diseases. 2001;37:878. doi: 10.1016/s0272-6386(01)80145-1. [DOI] [PubMed] [Google Scholar]
- 9.Cornélissen G, Halberg F, Bakken EE, Singh RB, Otsuka K, Tomlinson B, et al. 100 or 30 years after Janeway or Bartter, Healthwatch helps avoid “flying blind”. Biomedicine and Pharmacotherapy. 2004;58(Suppl 1):S69–86. doi: 10.1016/s0753-3322(04)80012-x. [DOI] [PubMed] [Google Scholar]
- 10.Chen CH, Cornélissen G, Halberg F. Left ventricular mass index as “outcome” related to circadian blood pressure characteristics. Scripta Medica. 1998;71:183–9. [Google Scholar]
- 11.Mancia G, Parati G. The role of blood pressure variability in end-organ damage. Joumal of Hypertension. 2003;21(Suppl 6):S17–23. doi: 10.1097/00004872-200307006-00004. [DOI] [PubMed] [Google Scholar]
- 12.Pickering TG, Harshfield GA, Devereux RB, Laragh JH. What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension. 1985;7:171–7. doi: 10.1161/01.hyp.7.2.171. [DOI] [PubMed] [Google Scholar]
- 13.Halberg F, Cornélissen G, Halberg E, Halberg J, Delmore P, Shinoda M, et al. Medtronic Continuing Medical Education Seminars. 4. 1988. Chronobiology of human blood pressure; p. 242. [Google Scholar]
- 14.Cornélissen G. Instrumentation and data analysis methods needed for blood pressure monitoring in Chronobiology. In: Scheving LE, Halberg F, Ehret CF, editors. Chronobiotechnology and Chronobiological Engineering. Martinus Nijhoff Publishers; Dordrecht: 1987. pp. 241–61. NATO ASI Series E 120. [Google Scholar]
- 15.Seligman SA. Diurnal blood pressure variation in pregnancy. Journal Obstet Gynaecol Brit Commonwealth. 1971;78:417–22. doi: 10.1111/j.1471-0528.1971.tb00295.x. [DOI] [PubMed] [Google Scholar]
- 16.Meis PJ, Halberg F, Buster JE, Marshall JR. Circadian rhythms in blood pressure, breast surface temperature and blood dehydroepiandrosterone sulfate in human pregnancy: potential chronotherapeutic markers. In: Walker CA, Winget CM, Soliman KFA, editors. Chronopharmacology and Chronotherapeutics. Florida A and M University Foundation; Tallahassee, Florida: 1981. pp. 159–76. [Google Scholar]
- 17.Cornélissen G, Sitka U, Tarquini B, Mainardi G, Panero C, Cugini P, et al. Chronobiologic approach to blood pressure during pregnancy and early extrauterine life. Progress in Clinical and Biological Research. 1990;341A:585–94. [PubMed] [Google Scholar]
- 18.Benedetto C, Zonca M, Marozio L, Dolci C, Carandente F, Massobrio M. Blood pressure patterns in normal pregnancy and in pregnancy-induced hypertension, preeclampsia, and chronic hypertension. Obstetrics and Gynecology. 1996;88:503–10. doi: 10.1016/0029-7844(96)00217-7. [DOI] [PubMed] [Google Scholar]
- 19.Miyamoto S, Shimokawa H, Sumioki H, Touno A, Nakano H. Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure during the third trimester in normal and preeclamptic pregnancies. American Journal of Obstetrics and Gynecology. 1988;158:393–9. doi: 10.1016/0002-9378(88)90162-7. [DOI] [PubMed] [Google Scholar]
- 20.Oney T, Meyer-Sabellek W. Variability of arterial blood pressure in normal and hypertensive pregnancy. Journal of Hypertension. 1990;(Suppl 86):S77–81. [PubMed] [Google Scholar]
- 21.White WB. Diurnal blood pressure and blood pressure variability in diabetic normotensive and hypertensive subjects. Journal of Hypertension. 1992;(Suppl 101):S35–41. doi: 10.1097/00004872-199204001-00008. [DOI] [PubMed] [Google Scholar]
- 22.Picketing TG. Blood pressure variability and ambulatory monitoring. Current Opinion in Nephrology and Hypertension. 1993;2:380–5. doi: 10.1097/00041552-199305000-00006. 1993 May. [DOI] [PubMed] [Google Scholar]
- 23.Sander D, Klingelhofer J. Diurnal systolic blood pressure variability is the strongest predictor of early carotid atherosclerosis. Neurology. 1996;47:500–7. doi: 10.1212/wnl.47.2.500. [DOI] [PubMed] [Google Scholar]
- 24.Singh RB, Cornélissen G, Weydahl A, Schwartzkopff O, Katinas G, Otsuka K, et al. Circadian heart rate and blood pressure variability considered for research and patient care. International Journal of Cardiology. 2003;87:9–28. doi: 10.1016/s0167-5273(02)00308-x. [DOI] [PubMed] [Google Scholar]
- 25.Consiglio Nazionale delle Ricerche: Standard del peso del neonato Italiano. Riv Ital Pediatr. 1980;6:153. [Google Scholar]
- 26.Gairdner D, Pearson J. A growth chart for premature and other infants. Archives of Disease in Childhood. 1971;46:783–7. doi: 10.1136/adc.46.250.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Shennan AH, Kissane J, de Swiet M. Validation of the SpaceLabs 90207 ambulatory blood pressure monitor for use in pregnancy. British Journal of Obstetrics and Gynaecology. 1993;100:904–8. doi: 10.1111/j.1471-0528.1993.tb15104.x. [DOI] [PubMed] [Google Scholar]
- 28.Halberg F. Chronobiology. Annual Review Physiology. 1969;31:675–725. doi: 10.1146/annurev.ph.31.030169.003331. [DOI] [PubMed] [Google Scholar]
- 29.Cornélissen G, Halberg F. Chronomedicine. In: Armitage P, Colton T, editors. Encyclopedia of Biostatistics. Vol. 2. Chichester, UK: John Wiley and Sons Ltd.; 2005. pp. 796–812. [Google Scholar]
- 30.Bingham C, Arbogast B, Cornélissen Guillaume G, Lee JK, Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia. 1982;9:397–439. [PubMed] [Google Scholar]
- 31.Hosmer DW, Lemeshow S. Applied logistic regression. Vol. 2. John Wiley and Sons; New York: 2000. p. 392. [Google Scholar]
- 32.Armitage P, Berry G. Statistical methods in medical research. 3. Blackwell Scientific Pub; Oxford: 1994. p. 620. [Google Scholar]
- 33.Yun AJ, Lee PY, Bazar KA. Temporal variation of autonomic balance and diseases during circadian, seasonal, reproductive, and lifespan cycles. Medical Hypotheses. 2004;63:155–62. doi: 10.1016/j.mehy.2004.02.030. [DOI] [PubMed] [Google Scholar]
- 34.Stewart JM. Transient orthostatic hypotension is common in adolescents. Journal of Pediatrics. 2002;140:418–24. doi: 10.1067/mpd.2002.122643. [DOI] [PubMed] [Google Scholar]
- 35.Maggioni C, Lucini D, Antinozzi R, Pagani M. Circadian rhythm of ANP, aldosterone and PRA in normotensive IUGR. Journal of Hypertension. 2001;19:1659–64. doi: 10.1097/00004872-200109000-00019. [DOI] [PubMed] [Google Scholar]
- 36.Redman CW, Beilin LJ, Bonnar J. Variability of blood pressure in normal and abnormal pregnancy. Perspectives in Nephrology and Hypertension. 1976;5:53–60. [PubMed] [Google Scholar]
- 37.Redman CW, Beilin LJ, Bonnar J. Reversed diurnal blood pressure rhythm in hypertensive pregnancies. Clinical Science and Molecular Medicine. 1976;(Suppl 3):687s–9s. doi: 10.1042/cs051687s. [DOI] [PubMed] [Google Scholar]
- 38.Beilin LJ, Deacon J, Michael CA, Vandongen R, Lalor CM, Barden AE. Circadian rhythms of blood pressure and pressor hormones in normal and hypertensive pregnancy. Clinical and Experimental Pharmacology and Physiology. 1982;9:321–6. doi: 10.1111/j.1440-1681.1982.tb00814.x. [DOI] [PubMed] [Google Scholar]
- 39.Halligan A, Shennan A, Lambert PC, de Swiet M, Taylor DJ. Diurnal blood pressure difference in the assessment of preeclampsia. Obstetrics and Gynecology. 1996;87:205–8. doi: 10.1016/0029-7844(95)00379-7. [DOI] [PubMed] [Google Scholar]
- 40.Halberg J, Halberg E, Hayes DK, Smith RD, Halberg F, Delea CS, et al. Schedule shifts, life quality and quantity modeled by murine blood pressure elevation and arthropod lifespan. International Journal of Chronobiology. 1980;7:17–64. [PubMed] [Google Scholar]
- 41.Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstetrics and Gynecology. 1990;76:1061–9. [PubMed] [Google Scholar]
- 42.Easterling TR, Benedetti TJ, Carlson KC, Brateng DA, Wilson J, Schmucker BS. The effect of maternal hemodynamics on fetal growth in hypertensive pregnancies. American Journal of Obstetrics and Gynecology. 1991;165:902–6. doi: 10.1016/0002-9378(91)90436-u. [DOI] [PubMed] [Google Scholar]
- 43.Schwarz R. Chronic hypertension and pregnancy. Zentralblatt fur Gynakologie. 1983;105:7–18. [PubMed] [Google Scholar]
- 44.Vasapotlo B, Valensise H, Novelli GP, Larciprete G, Di Pierro G, Altornare F, et al. Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction. Ultrasound in Obstetrics and Gynecology. 2002;20:452–7. doi: 10.1046/j.1469-0705.2002.00847.x. [DOI] [PubMed] [Google Scholar]
- 45.Warkentin B. Late gestosis as a compensation mechanism in fetal growth retardation and its disruption by anti-hypertensive therapy. Geburtshilfe und Frauenheilkunde. 1990;50:194–8. doi: 10.1055/s-2007-1026461. [DOI] [PubMed] [Google Scholar]
- 46.Steer PJ, Little MP, Kold-Jensen T, Chapple J, Elliott P. Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. British Medical Journal. 2004;329:1312. doi: 10.1136/bmj.38258.566262.7C. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Waugh J, Perry IJ, Halligan AW, De Swiet M, Lambert PC, Penny JA, et al. Birth weight and 24-hour ambulatory blood pressure in nonproteinuric hypertensive pregnancy. American Journal of Obstetrics and Gynecology. 2000;183:633–7. doi: 10.1067/mob.2000.106448. [DOI] [PubMed] [Google Scholar]
- 48.Ng PH, Waiters WA. The effects of chronic maternal hypotension during pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1992;32:14–6. doi: 10.1111/j.1479-828x.1992.tb01888.x. [DOI] [PubMed] [Google Scholar]
- 49.Schneider KT. Pregnancy-induced hypertension: maternal and fetal hemodynamics. Archives of Gynecology and Obstetrics. 1989;245:240–4. doi: 10.1007/BF02417259. [DOI] [PubMed] [Google Scholar]
- 50.Zamudio S, Palmer SK, Dahms TE, Berman JC, McCullough RG, McCullough RE, et al. Blood volume expansion, preeclampsia, and infant birth weight at high altitude. Journal of Applied Physiology. 1993;75:1566–73. doi: 10.1152/jappl.1993.75.4.1566. [DOI] [PubMed] [Google Scholar]
- 51.Steer PJ. Maternal hemoglobin concentration and birth weight. American Journal of Clinical Nutrition. 2000;71(5 Suppl):1285S–7S. doi: 10.1093/ajcn/71.5.1285s. [DOI] [PubMed] [Google Scholar]
- 52.Blankson ML, Goldenberg RL, Cutter G, Cliver SP. The relationship between maternal hematocrit and pregnancy outcome: black-white differences. Journal of the National Medical Association. 1993;85:130–4. [PMC free article] [PubMed] [Google Scholar]
- 53.Naeye RL. Causes and consequences of placental growth retardation. Journal of American Medical Association. 1978;239:1145–7. [PubMed] [Google Scholar]
- 54.Abrams B, Newman V. Small-for-gestational-age birth: maternal predictors and comparison with risk factors of spontaneous preterm delivery in the same cohort. American Journal of Obstetrics and Gynecology. 1991;164:785–90. doi: 10.1016/0002-9378(91)90516-t. [DOI] [PubMed] [Google Scholar]
- 55.Singer JE, Westphal M, Niswander K. Relationship of weight gain during pregnancy to birth weight and infant growth and development in the first year of life. Obstetrics and Gynecology. 1968;31:417–23. doi: 10.1097/00006250-196803000-00021. [DOI] [PubMed] [Google Scholar]
- 56.Cornélissen G, Otsuka K, Chen CH, Kumagai Y, Watanabe Y, Halberg F, et al. Nonlinear relation of the circadian blood pressure amplitude to cardiovascular disease risk. Scripta Medica. 2000;73:85–94. [Google Scholar]
- 57.Parati G, Mancia G. Blood pressure variability as a risk factor. Blood Pressure Monitoring. 2001;6:341–7. doi: 10.1097/00126097-200112000-00014. [DOI] [PubMed] [Google Scholar]
- 58.Scarpelli PT, März W, Cornélissen G, Romano S, Livi R, Scarpelli L, et al. Blood pressure self-measurement in schools for rhythmometric assessment of hyperbaric impact to gauge pressure ‘excess’. ISAM 1985, Proc. Int. Symp. Ambulatory Monitoring; Padua. March 29–30, 1985; CLEUP Editore; 1986. pp. 229–37. [Google Scholar]
- 59.Kumagai Y, Shiga T, Sunaga K, Cornélissen G, Ebihara A, Halberg F. Usefulness of circadian amplitude of blood pressure in predicting hypertensive cardiac involvement. Chronobiologia. 1992;19:43–58. [PubMed] [Google Scholar]
- 60.Watanabe Y, Cornélissen G, Halberg F, Bingham C, Siegelova J, Otsuka K, et al. Incidence pattern and treatment of a clinical entity, over-swinging or circadian hyper-amplitude-tension (CHAT) Scripta Medica. 1997;70:245–61. [Google Scholar]
- 61.Scarpelli PT, Romano S, Livi R, et al. Instrumentation for human blood pressure rhythm assessment by self-measurement. In: Scheving LE, Halberg F, Ehret CF, editors. Chronobiotechnology and Chronobiological Engineering. Martinus Nijhoff; The Netherlands: 1987. pp. 304–9. [Google Scholar]
- 62.Müller-Bohn T, Cornélissen G, Halhuber M, et al. CHAT und Schlagfall. Deutsche Apotheker Zeitung. 2002;142:366–70. [Google Scholar]
- 63.Halberg F, Cornélissen G, Schwartzkopff O, Hardeland R, Ulmer W. Messung und chronobiologische Auswertung der Variabilitäiten von Blutdruck und Herzfrequenz zur Prophylaxe schwerwiegender Krankheiten. Proc Leibniz Soz. 2003;54:127–56. [Google Scholar]
- 64.Otsuka K, Cornélissen G, Halberg F. Predictive value of blood pressure dipping and swinging with regard to vascular disease risk. Clinical Drug Investigation. 1996;11:20–31. [Google Scholar]
- 65.Cornélissen G, Otsuka K, Chen CH-H, Singh RB, Halberg F. Circadian hyper-amplitude- tension (CHAT) and an elevated pulse pressure are separate cardiovascular disease risk factors. In press. [Google Scholar]
